These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30222247)

  • 1. Autophagy and mitochondrial metabolism: insights into their role and therapeutic potential in chronic myeloid leukaemia.
    Baquero P; Dawson A; Helgason GV
    FEBS J; 2019 Apr; 286(7):1271-1283. PubMed ID: 30222247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells.
    Kuntz EM; Baquero P; Michie AM; Dunn K; Tardito S; Holyoake TL; Helgason GV; Gottlieb E
    Nat Med; 2017 Oct; 23(10):1234-1240. PubMed ID: 28920959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors.
    Calabretta B; Salomoni P
    Leuk Lymphoma; 2011 Feb; 52 Suppl 1(Suppl 1):54-9. PubMed ID: 21250825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting quiescent leukemic stem cells using second generation autophagy inhibitors.
    Baquero P; Dawson A; Mukhopadhyay A; Kuntz EM; Mitchell R; Olivares O; Ianniciello A; Scott MT; Dunn K; Nicastri MC; Winkler JD; Michie AM; Ryan KM; Halsey C; Gottlieb E; Keaney EP; Murphy LO; Amaravadi RK; Holyoake TL; Helgason GV
    Leukemia; 2019 Apr; 33(4):981-994. PubMed ID: 30185934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia.
    Khalaf A; de Beauchamp L; Kalkman E; Rattigan K; Himonas E; Jones J; James D; Shokry ESA; Scott MT; Dunn K; Tardito S; Copland M; Sumpton D; Shanks E; Helgason GV
    Sci Transl Med; 2024 Jun; 16(751):eadi5336. PubMed ID: 38865484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT1 regulates metabolism and leukemogenic potential in CML stem cells.
    Abraham A; Qiu S; Chacko BK; Li H; Paterson A; He J; Agarwal P; Shah M; Welner R; Darley-Usmar VM; Bhatia R
    J Clin Invest; 2019 Jun; 129(7):2685-2701. PubMed ID: 31180336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia.
    Muselli F; Peyron JF; Mary D
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting survival pathways in chronic myeloid leukaemia stem cells.
    Sinclair A; Latif AL; Holyoake TL
    Br J Pharmacol; 2013 Aug; 169(8):1693-707. PubMed ID: 23517124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
    Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
    Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy in chronic myeloid leukaemia: stem cell survival and implication in therapy.
    Helgason GV; Mukhopadhyay A; Karvela M; Salomoni P; Calabretta B; Holyoake TL
    Curr Cancer Drug Targets; 2013 Sep; 13(7):724-34. PubMed ID: 23941517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting ULK1 in cancer stem cells: insight from chronic myeloid leukemia.
    Ianniciello A; Helgason GV
    Autophagy; 2022 Jul; 18(7):1734-1736. PubMed ID: 35227175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myeloid leukemia stem cells.
    Houshmand M; Simonetti G; Circosta P; Gaidano V; Cignetti A; Martinelli G; Saglio G; Gale RP
    Leukemia; 2019 Jul; 33(7):1543-1556. PubMed ID: 31127148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical perspectives of concepts on neoplastic stem cells and stem cell-resistance in chronic myeloid leukemia.
    Valent P; Deininger M
    Leuk Lymphoma; 2008 Apr; 49(4):604-9. PubMed ID: 18398718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance in chronic myeloid leukemia: definitions and novel therapeutic agents.
    Talati C; Pinilla-Ibarz J
    Curr Opin Hematol; 2018 Mar; 25(2):154-161. PubMed ID: 29266016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effect of imatinib and ponatinib on autophagy and miRNome in chronic myeloid leukemia.
    Kayabasi C; Okcanoglu TB; Yelken BO; Asik A; Susluer SY; Avci CB; Saydam G; Gunduz C
    Gene; 2017 Dec; 637():173-180. PubMed ID: 28942039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia Stem Cells in Chronic Myeloid Leukemia.
    Shan Y; DeSouza N; Qiu Q; Li S
    Adv Exp Med Biol; 2019; 1143():191-215. PubMed ID: 31338821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Fas-associated phosphatase 1 in leukemia stem cell persistence during tyrosine kinase inhibitor treatment of chronic myeloid leukemia.
    Huang W; Luan CH; Hjort EE; Bei L; Mishra R; Sakamoto KM; Platanias LC; Eklund EA
    Leukemia; 2016 Jul; 30(7):1502-9. PubMed ID: 26984787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic alterations mediated by STAT3 promotes drug persistence in CML.
    Patel SB; Nemkov T; Stefanoni D; Benavides GA; Bassal MA; Crown BL; Matkins VR; Camacho V; Kuznetsova V; Hoang AT; Tenen DE; Wolock SL; Park J; Ying L; Yue Z; Chen JY; Yang H; Tenen DG; Ferrell PB; Lu R; Darley-Usmar V; D'Alessandro A; Bhatia R; Welner RS
    Leukemia; 2021 Dec; 35(12):3371-3382. PubMed ID: 34120146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function.
    Xiao M; Ai H; Li T; Rajoria P; Shahu P; Li X
    Biochem Biophys Res Commun; 2016 Apr; 472(4):610-6. PubMed ID: 26966074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapies and autophagy: new insights from chronic myeloid leukemia.
    Salomoni P; Calabretta B
    Autophagy; 2009 Oct; 5(7):1050-1. PubMed ID: 19713759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.